Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
with over 100 in The Division of Informatics, Imaging and Data Sciences, and plug-in to our network of over 400 who work across the University in different disciplines allied to the Division including
-
the Research Platforms Team, around 25 technical IT specialists — and growing — many with a research background themselves. We develop and support e-infrastructure platforms for the University research community
-
also work closely with the ACED Inequalities Theme PPI lead, PPI Champion, and PPI group to support engagement of patients and members of the public in ACED research. They will prepare summary reports
-
We seek to appoint three outstanding and ambitious scientists to senior lectureship / reader positions based within the Manchester Institute of Biotechnology (MIB) at the University of Manchester
-
BACKGROUND The project is an industry-academic collaboration, funded through the UKRI IAA scheme. The academic lead is based at the Royce Hub building at the University of Manchester, where the labs
-
We are recruiting an ambitious, self-motivated Research Associate to join Dr Williams’ research group focussing on how the embryonic development of individual cells within the embryo must respond
-
The University of Manchester is looking for a motivated and enthusiastic Lecturer in Pharmacy Practice to join the Division of Pharmacy & Optometry. This post is to cover maternity leave, and we
-
signalling dynamics regulate cell fate decisions during Drosophila development. The successful candidate will be practical, organized and independent, with excellent communication skills. Applicants should
-
. HALo aims to establish the UK as a world leader in long-acting therapeutic (LAT) development by tackling key challenges in formulation science, pharmacokinetics, and sustainability. The project focuses
-
for the trial sponsor, clinical site, managing CRO, funder and other third parties. The post holder will also support the development of other ongoing or new clinical trials and manage the submission of future